Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies von Falchook, Gerald, Rosen, Seth, LoRusso, Patricia, Watts, Justin, Gupta, Shilpa, Coombs, Catherine C., Talpaz, Moshe, Kurzrock, Razelle, Mita, Monica, Cassaday, Ryan, Harb, Wael, Peguero, Julio, Smith, David C., Piha-Paul, Sarina A., Szmulewitz, Russ, Noel, Marcus S., Yeleswaram, Swamy, Liu, Phillip, Switzky, Julie, Zhou, Gongfu, Zheng, Fred, Mehta, Amitkumar

Volltext

Abstract A093: Phase 1/2 study of INCB054329, a bromodomain and extraterminal (BET) protein inhibitor, in patients (pts) with advanced malignancies von Falchook, Gerald, Talpaz, Moshe, Mita, Monica, Szmulewitz, Russ, Piha-Paul, Sarina, Harb, Wael, Morgensztern, Daniel, Kaplan, Jason, Munster, Pamela, Cornell, Robert F., Zheng, Fred, Yeleswaram, Swamy, Zhou, Gongfu, Cassaday, Ryan

Volltext